Delivery Order SPE2DB22D3501-SPE2DB24FVG07
Award Date 4/11/24
Potential Completion Date 4/12/24
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,728,753 units of Ondansetron ODT 8 mg tablets. The $3,297.64 contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) valued up...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,874.12 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,144,293 units of Ondansetron ODT 4 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,247.48 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp. for the supply of 4,565,469,507 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The contract has an ultimate completion date of August 16, 2024 and was awarded on August 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these critical medical supplies to support various military treatment...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,734.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 8 mg tablets. The contract has a completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 4,563,971,285 units of the medication Ondansetron ODT 4 mg Tablet. The $24,983.87 contract has a performance period through March 15, 2024. Amerisourcebergen Drug Corp serves as a prime contractor for DLA, providing a wide range of pharmaceutical products and medical supplies...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,249,029 units of Ondansetron ODT 4 MG Tablets in 30-count packages. The $10,530.00 contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp also holds an Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,235,087 units of Ondansetron ODT 4 mg tablets. The $4,464.67 contract has an ultimate completion date of April 11, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor and serves as the primary supplier of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,125,413 units of the prescription drug Ondansetron ODT 8mg Tablet. The contract, valued at $1,189.99, has an ultimate completion date of April 1, 2024. As the prime contractor, Amerisourcebergen Drug Corp will deliver these pharmaceutical products from its Corporate Office in Conshohocken, Pennsylvania to support...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,533.85 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the Amerisourcebergen Corporation. The contract is for the supply of 4,564,325,614 units of the prescription drug Ondansetron ODT 4 mg Tablet 30s. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,635,055 units of the pharmaceutical product Ondansetron ODT 4 MG Tablet 30S. The contract has a potential value of $5,262.72 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVG07Delivery Order
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,249,283 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The award, valued at $6,719.95, has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of pharmaceuticals and medical supplies to military treatment programs and facilities worldwide. This delivery order does not have a set-aside designation.
Generated 7/11/24, 9:24 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 4/11/24 |